Back

High-intensity lipid-lowering therapy accelerates early plaque regression: a FLOWPROMOTE sub study.

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes (5) Noninvasive Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Nadia Iraqi

Aarhus University Hospital, Aarhus (Denmark)

3 More presentations in this session

Presentation thumbnail
Prophylactic anticoagulation for left ventricular thrombus in patients with anterior myocardial infarction
Doctor A. Gajulapalli (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
Professor S. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of potent p2y12 inhibitors versus clopidogrel in complex percutaneous coronary intervention: a systematic review and meta-analysis
Doctor F. Stabile (Palermo, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes (5)

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
A meta analysis of effects of high-intensity statin and pcsk-9 inhibitor therapies on coronary plaque burden
thumbnail
Congress Presentation
PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis
thumbnail
Congress Presentation
The efficacy of dual lipid-lowering therapy with ezetimibe and statin on plaque volume regression among patients following percutaneous coronary intervention: a meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources